Clinical trials
Observational Tuberculosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Unknown status | 4 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huashan Hospital | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Beijing Chest Hospital | 1 |
| Beijing Children's Hospital | 1 |
| Chinese University of Hong Kong | 1 |
| Creative Biosciences (Guangzhou) Co., Ltd. | 1 |
| First Affiliated Hospital of Ningbo University | 1 |
| Peking University Third Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Taichung Veterans General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 14 |
| Latent Tuberculosis | 2 |
| Adenocarcinoma | 1 |
| Bronchitis | 1 |
| Bronchitis, Chronic | 1 |
| Carcinoma | 1 |
| Carcinoma, Adenosquamous | 1 |
| Carcinoma, Large Cell | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Squamous Cell | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.